LivaNova (LIVN) Accumulated Depreciation & Amortization (2014 - 2025)

LivaNova's (LIVN) quarterly Accumulated Depreciation & Amortization came in at $242.2 million in Q4 2025, up 17.15% year-on-year from $206.8 million in Q4 2024, and up 17.15% quarter-over-quarter from $206.8 million in Q4 2024.

LivaNova (LIVN) Accumulated Depreciation & Amortization (2014 - 2025) Analysis & Trends

LivaNova has disclosed Accumulated Depreciation & Amortization across 12 years of filings, most recently posting $242.2 million for Q4 2025.

  • Accumulated Depreciation & Amortization for Q4 2025 came in at $242.2 million, up 17.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $242.2 million (up 17.15% YoY), and the FY2025 annual result was $242.2 million, up 17.15% from the prior year.
  • Accumulated Depreciation & Amortization came in at $242.2 million for Q4 2025 at LivaNova, up from $206.8 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $242.2 million in Q4 2025 to a low of $161.8 million in Q4 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $196.0 million (2023), against an average of $196.4 million.
  • Across the five-year window, Accumulated Depreciation & Amortization climbed 1.99% in 2021 and climbed 17.15% in 2025, its largest moves.
  • LivaNova's Accumulated Depreciation & Amortization stood at $161.8 million in 2021, then advanced by 8.24% to $175.1 million in 2022, then grew by 11.94% to $196.0 million in 2023, then gained by 5.47% to $206.8 million in 2024, then rose by 17.15% to $242.2 million in 2025.
  • The last three Accumulated Depreciation & Amortization figures came in at $242.2 million (Q4 2025), $206.8 million (Q4 2024), and $196.0 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 LivaNova 4.34 Bn 3.76 Bn 243.75 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 242.21 Mn
Dec 31, 2025 242.21 Mn
Dec 31, 2024 206.75 Mn
Dec 31, 2024 206.75 Mn
Dec 31, 2023 196.04 Mn
Dec 31, 2023 196.04 Mn
Dec 31, 2022 175.12 Mn
Dec 31, 2022 175.12 Mn
Dec 31, 2021 161.79 Mn
Dec 31, 2021 161.79 Mn
Dec 31, 2020 158.62 Mn
Dec 31, 2020 158.62 Mn
Dec 31, 2019 153.99 Mn
Dec 31, 2019 153.99 Mn
Dec 31, 2018 130.04 Mn
Dec 31, 2018 130.04 Mn
Dec 31, 2017 103.21 Mn
Dec 31, 2017 103.21 Mn
Dec 31, 2016 85.36 Mn
Dec 31, 2016 85.36 Mn